Genitourinary Cancer

Latest News

Blue image of kidneys with renal tubules highlighted in red
Nivolumab Plus Cabozantinib Effective Long-Term for Advanced RCC

February 15th 2025

Patients with advanced RCC who were treated with nivolumab plus cabozantinib had a median PFS of 16.4 months compared with 8.3 months from sunitinib alone.

Line illustration of the bladder and prostate on a cerulean background
Darolutamide-ADT Combination Lengthens rPFS in mHSPC Regardless of Disease Volume

February 15th 2025

Graphic of care providers, patients, and families conversing near large computers and health charts
Digital Health Tool Helps Patients With Prostate Cancer During Consultations

February 14th 2025

Line illustration of the male genitourinary system on a yellow background
177Lu-PSMA-617 With Enzalutamide for mCRPC Boosts OS, QOL

February 13th 2025

Rendering of prostate cancer cells
Clinical Practice Gaps Persist in Biomarker Testing for mCRPC Management

February 13th 2025

Video Interviews
Podcasts
Oncology Nursing News
Key Advances in Cancer Survivorship Toxicity Management
Carbone Cancer Center Expert Shares Biggest Updates in Kidney Cancer Treatment

More News